In non-small cell lung cancer (NSCLC) patients with overweight or obesity, metformin may improve lung cancer-specific ...

Preclinical and clinical data demonstrate that neutralizing GDF-15 with visugromab effectively alleviates cancer-induced cachexia, characterized by severe weight and muscle mass loss Patients ...

Metformin may improve lung cancer-specific clinical outcomes in obese and overweight lung cancer patients and enhance immunotherapy efficacy in this growing population as well,” researchers concluded.

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have reported results from the first-ever clinical trial ...

Past studies across several cancer types have looked at the impact of dietary interventions, such as a high-fiber diet, on ...

Interleukin-2 (IL-2) is a well-known cytokine that plays a crucial role in stimulating immune cells, including natural killer (NK) cells and cytotoxic T cells. It has been studied as an immunotherapy ...

MSK myeloma specialist Dr Urvi Shah, who presented these findings at the 2024 American Society of Hematology (ASH) annual ...

Glyphosate exposure in mice exacerbates Alzheimer's-like neuropathologies, increases neuroinflammation, and leaves lasting ...

Dec. 3, 2024 — Scientists created a new therapeutic design for glioblastoma, the deadliest form of brain cancer. The lab engineered molecules called trispecifics that connect cancer-killing T ...

Dec. 5, 2024 — A groundbreaking phase one clinical trial explored a novel cell-based immunotherapy for breast cancer. The study focuses on a new treatment approach that aims to harness the body ...